The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Meniere's Disease — Surgical Treatment

Surgical options for medically refractory Meniere's disease — endolymphatic sac procedures, intratympanic therapy, vestibular nerve section, and labyrinthectomy.

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our KBB (Kulak Burun Boğaz) department. Book Appointment →

What is Meniere's Disease — Surgical Treatment?

Meniere's disease is a chronic inner-ear disorder defined by recurrent episodic vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness, attributed to endolymphatic hydrops. About 5–10% of patients fail medical management (low-salt diet, betahistine, diuretics, lifestyle measures) and proceed to procedural therapy.

Stepwise surgical algorithm: (1) endolymphatic sac decompression or shunt — preserves hearing, modest vertigo control; (2) intratympanic gentamicin — chemical labyrinthectomy, hearing risk ~10–30%; (3) vestibular nerve section via retrosigmoid or middle fossa — hearing-preserving, ~95% vertigo control; (4) labyrinthectomy — used only with non-serviceable hearing, definitive vertigo cure.

Patient selection requires audiologic, vestibular (VNG, vHIT, VEMP), and imaging (MRI delayed-Gd hydrops protocol) workup. Bilateral disease and hearing status drive the decision. Surgeons consider age, comorbidity, occupation (e.g., pilots), and contralateral ear function.

Symptoms

Episodic spontaneous vertigo lasting 20 minutes to 12 hours despite medical therapy
Progressive low-frequency sensorineural hearing loss
Roaring tinnitus and aural fullness during attacks
Drop attacks (Tumarkin otolithic crises)
Disabling motion sickness and falls
Functional disability score 4–6 (AAO-HNS) — work and social impairment

Risk Factors

Failure of 6–12 months of optimal medical therapy
Frequent disabling vertigo episodes (>2/month)
Documented endolymphatic hydrops on delayed-Gd MRI
Drop attacks despite medication
Non-serviceable hearing in the affected ear (favors labyrinthectomy)
Bilateral disease (limits ablative options)
Cochlear implant candidates with intractable vertigo (combined approach)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent vertigo attacks despite 6 months of medical therapy
  • Progressive hearing decline with disabling vertigo
  • Tumarkin drop attack — emergency referral, fall and injury risk
  • Bilateral Meniere's disease — multidisciplinary planning required
  • Postoperative vertigo recurrence — reimaging and revision evaluation

Treatment Methods

01
Endolymphatic sac decompression/shunt: outpatient mastoidectomy, hearing preservation 90%, vertigo control 60–70% at 2 years
02
Intratympanic gentamicin titration: low-dose (single shot or 2–3 doses), monitored vestibular ablation, 80–90% vertigo control, hearing loss 10–30%
03
Vestibular nerve section (retrosigmoid or middle fossa): hearing-preserving denervation, 95% vertigo control, requires craniotomy and ICU stay
04
Transmastoid labyrinthectomy: definitive ablation, 99% vertigo control, complete hearing loss — reserved for non-serviceable hearing
05
Cochlear implantation in selected cases of Meniere's-related deafness post-labyrinthectomy
06
Postoperative vestibular rehabilitation: gaze stabilization, balance retraining, gradual return to activity over 6–12 weeks
07
Adjunctive medical therapy: continued low-salt diet, ototoxic-drug avoidance, audiologic follow-up

Which Department to Visit?

You can visit our KBB (Kulak Burun Boğaz) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About KBB (Kulak Burun Boğaz) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.